CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 93 filers reported holding CARDIFF ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $71,646 | +41554.7% | 48,739 | -53.1% | 0.00% | – |
| Q1 2023 | $172 | -12.7% | 103,942 | -26.2% | 0.00% | – |
| Q4 2022 | $197 | -99.9% | 140,767 | -29.5% | 0.00% | – |
| Q3 2022 | $308,000 | -64.4% | 199,787 | -49.2% | 0.00% | -100.0% |
| Q2 2022 | $866,000 | +22.5% | 393,603 | +38.1% | 0.00% | – |
| Q1 2022 | $707,000 | -71.9% | 284,994 | -32.0% | 0.00% | -100.0% |
| Q4 2021 | $2,517,000 | +196.5% | 418,880 | +228.5% | 0.00% | 0.0% |
| Q3 2021 | $849,000 | -71.6% | 127,498 | -60.5% | 0.00% | -50.0% |
| Q1 2021 | $2,991,000 | +419.3% | 322,962 | +908.0% | 0.00% | – |
| Q4 2020 | $576,000 | -56.8% | 32,041 | -65.9% | 0.00% | -100.0% |
| Q3 2020 | $1,333,000 | – | 93,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $16,797,000 | 13.61% |
| Octagon Capital Advisors LP | 982,753 | $6,545,000 | 1.61% |
| Altium Capital Management LP | 348,888 | $2,324,000 | 0.61% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $683,000 | 0.35% |
| Eventide Asset Management | 1,670,399 | $11,125,000 | 0.15% |
| Artal Group S.A. | 750,000 | $4,995,000 | 0.11% |
| Virtus ETF Advisers LLC | 25,770 | $172,000 | 0.08% |
| HighVista Strategies LLC | 15,501 | $103,000 | 0.07% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 13,500 | $90,000 | 0.05% |
| SCHOLTZ & COMPANY, LLC | 16,625 | $111,000 | 0.04% |